- A gross income of $250,000 or more per annum in each of the previous two financial years; or
- Net assets of at least $2.5 million; and
- A verified Qualified Accountant’s certificate given no more than two (2) years ago confirming the Sophisticated Investor status. Please refer to the Corporations Act: Specifically Section 708(08) and Section s761G(7)
About Wellnex Life
Wellnex Life (ASX: WNX) is an Australian brand and distribution company of customer-focused health and wellness products. The company’s large portfolio, first-to-market strategy and established retail distribution network provide an attractive business model for growth and profitability. Wellnex’s mission is to deliver health, wellness, and vitality solutions to consumers in Australia and worldwide.
AGILITY
Remains at our core, as we continue to capitalise on proven relationships, explore new products, technology and joint ventures.
PASSION
In everything we do, we look after our environment, our people and our communities. Our business reflects our passion for sustainability and transparency.
PRINCIPLED
Wholly Australian-owned, we’re proudly authentic and always fully accountable for our actions and decisions across the entire supply chain.
INNOVATION
We bring ingenuity and innovative thinking to every aspect of our business – moving swiftly with our evolving world. We are Category Disruptors.
Access to SP Angel’s research via this website is subject to the following terms and conditions. SP Angel (‘SPA’) does not deal with individual or private investors (save in connection with corporate finance business). SPA’s research is thus not prepared for private investors and does not take into account any particular investor’s or class of investors’ investment objectives. You are therefore not being granted access to SPA research in your capacity as an investor or SPA client or potential investor or client. You understand that SPA is not offering you any financial service. Members of SPA’s Research department are not permitted to interact with private investors and you should not attempt to contact them.
Pitt Street Research: Wellnex Life (ASX: WNX)
Pitt Street Research have published research on Wellnex Life, providing an overview of the Company, their investment thesis and valuation range.
View ResearchPASSION
In everything we do, we look after our environment, our people and our communities. Our business reflects our passion for sustainability and transparency.
INNOVATION
We bring ingenuity and innovative thinking to every aspect of our business – moving swiftly with our evolving world. We are Category Disruptors.
AGILITY
Remains at our core, as we continue to capitalise on proven relationships, explore new products, technology and joint ventures.
PRINCIPLED
Wholly Australian-owned, we’re proudly authentic and always fully accountable for our actions and decisions across the entire supply chain.
INNOVATION
We bring ingenuity and innovative thinking to every aspect of our business – moving swiftly with our evolving world. We are Category Disruptors.
PASSION
In everything we do, we look after our environment, our people and our communities. Our business reflects our passion for sustainability and transparency.
PRINCIPLED
Wholly Australian-owned, we’re proudly authentic and always fully accountable for our actions and decisions across the entire supply chain.
AGILITY
Remains at our core, as we continue to capitalise on proven relationships, explore new products, technology and joint ventures.
Our Team
Board
Management
‹
Ash Vesali
Executive Chair
Ash Vesali
Executive Chair
A track record of guiding CXOs and boards through operational excellence, restructuring, and commercialisation. Bringing deep expertise in capital efficiency, revenue growth, market expansion across utilities, consumer, industrials, and technology sectors.Prior Forbes Technology Council member and speaker at several global forums on commercialisation and value creation.
Jeffrey Yeh
Non-Executive Director
Jeffrey Yeh
Non-Executive Director
Jeffrey Yeh is an experienced all-rounded entrepreneur, with over 21 years’ experience in all aspects of pharmaceutical sales, marketing, production, quality assurance, operations, logistics, finance and management. Jeffrey co-founded Homart Pharmaceuticals in 2002, and since then has grown Homart into a premier and award winning manufacturing and brand business with over 200 employees and an international presence.
Eric Jiang
Senior Independent
Non-Executive Director
Eric Jiang
Senior Independent
Non-Executive Director
Eric Jiang is a corporate adviser and independent board member. Eric brings a distinctive understanding of the cultural, economic and strategic context in which Australian businesses engage with China. Eric has previously sat on the boards of ASX listed corporates Connexion Media Limited (ASX:CXZ), Perpetual Resources Limited (ASX:PEC) and Wingara AG Limited (ASX:WNR). He is a past President of The Chinese Community Council of Australia.
›
‹
Eric Jiang
Senior Independent
Non-Executive Director
Eric Jiang
Senior Independent
Non-Executive Director
Eric Jiang is a corporate adviser and independent board member. Eric brings a distinctive understanding of the cultural, economic and strategic context in which Australian businesses engage with China. Eric has previously sat on the boards of ASX listed corporates Connexion Media Limited (ASX:CXZ), Perpetual Resources Limited (ASX:PEC) and Wingara AG Limited (ASX:WNR). He is a past President of The Chinese Community Council of Australia.
Jeffrey Yeh
Non-Executive Director
Jeffrey Yeh
Non-Executive Director
Jeffrey Yeh is an experienced all-rounded entrepreneur, with over 21 years’ experience in all aspects of pharmaceutical sales, marketing, production, quality assurance, operations, logistics, finance and management. Jeffrey co-founded Homart Pharmaceuticals in 2002, and since then has grown Homart into a premier and award winning manufacturing and brand business with over 200 employees and an international presence.
Ash Vesali
Executive Chair
Ash Vesali
Executive Chair
A track record of guiding CXOs and boards through operational excellence, restructuring, and commercialisation. Bringing deep expertise in capital efficiency, revenue growth, market expansion across utilities, consumer, industrials, and technology sectors.
Prior Forbes Technology Council member and speaker at several global forums on commercialisation and value creation.
›